Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- Economic Evaluation of Healthcare Technologies
- Measurement and Valuation of Resources
- Measurement and Valuation of Health Outcomes
- Design and Evaluation of Healthcare Systems
- Economics of Population Health
- Ageing
- Clinical Guidelines
- All Completed Studies
- NHS and the UK Healthcare System
- All Current Studies - Clinical Trials (Economic Evaluation)
- Economics of Blood Transfusion
- Economics of Screening
- Genomic Technologies
- Methodological Developments in Economic Evaluation
- Modelling
- Other Economic Evaluation Work (not falling under any other headings)
- Estimating Costs for Economic Evaluation
- DCE Research at HERC
- Willingness to Pay
- Measurement of Capabilities
- Health Inequalities
- Patient Safety
- Radon
- Maternal and Child Health
- Mental Health
- Heart Disease
- Diabetes
- Disease Cost Studies
- Global Health
- Population Datasets
- MAPS: reporting statement for studies mapping onto preference-based outcome measures
- Coeliac Disease
- Kusal Lokuge
- Inna Thalmann
- Ines Rombach
- Joel Smith
- David Jones
- Winnie Mei
- Liam McMorrow
- Frauke Becker
- Alastair Gray
- Borislava Mihaylova
- Iryna Schlackow
- James Buchanan
- Helen Dakin
- Seamus Kent
- José Leal
- Ramon Luengo-Fernandez
- Laurence Roope
- Liz Stokes
- Apostolos Tsiachristas
- Sarah Wordsworth
- Jane Wolstenholme
- Filipa Landeiro
- Stavros Petrou
- Sasha Shepperd
- Judit Simon
- Yaling Yang
- Oliver Rivero-Arias
- Adrian Towse
- Paul Fenn
- Mandy Fruin
- Darren Barber
- Sophie Diarra
- Stephen Rocks
- Matthew Little
- Mara Violato
- Ana Gibertoni Cruz
- Mi Jun Keng
- Francesco Salustri
- Philip Clarke
- Liz Morrell
- Patrick Fahr
- Paolo Candio
- Koen Pouwels
- HERC in the news - 2016 CMO Annual Report 'Generation Genome'
- HERC Newsletter - Issue 21 OUT NOW!
- Previous News
- How do pay rises affect inequality?
- NEW: DPhil Opportunities
- Chronic kidney disease policy model
- OUT NOW: HERC database of mapping studies version 6.0
- HERC Newsletter - Issue 22 OUT NOW!
- Job Opportunity: Senior Researcher in Health Economics
- REGISTRATION NOW OPEN: Resource Allocation in Personalised Medicine: Evaluation, Translation & Ethics
- Two new vacancies at HERC
- NEW: HERC database of health economics and genomics studies
- HERC Newsletter - Issue 23 OUT NOW!
- NDPH is five
- Campaigns about unnecessary antibiotic use and antibiotic resistance could backfire
- Job Opportunity: Senior Researcher/Researcher in Health Economics
- HERC Newsletter - Issue 24 OUT NOW!
- Congratulations to Mara Violato on being awarded the title of University Research Lecturer!
- DPhil Opportunities at HERC
- HERC announcement: Change in leadership
- HERC Newsletter - Issue 25 OUT NOW!
- Short courses in health economics: Introduction to Health Economic Evaluation - Booking now open for 2019
- Health expenditure on patients with multiple conditions
- New Job Opportunity: Researcher in Health Economics
- Applied Methods of Cost-Effectiveness Analysis (3-Day) - Booking now open for July 2019!
- Ten-year outcomes of the Arterial Revascularisation Trial
- Statin therapy reduces cardiovascular disease risk in older people
- Philip Clarke, presents 'The origins of health economic evaluation' at Centre for Health Economics, University of York
- HERC database of mapping studies
-
Publications Supporting Material
- Mixed treatment comparison of repeated measurements of a continuous endpoint
- The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
- Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score
- OPTIONS
- Review of statistical methods for analysing healthcare, resources and costs - additional material
- WHO Handbook on Indoor Radon: a public health perspective
- Mapping Modified Rankin Scale responses to EQ-5D utility values
- Supporting Material for Treatment Pathways, Resource Use, and Costs of Endovascular Coiling Versus Surgical Clipping After aSAH
- Supporting materials to the BMJ paper on the economic evaluation of the DiGEM study
- SF-12 Responses and EQ-5D Utility Values
- Supporting material for UKPDS Study No.65
- Variance-covariance matrices for mapping algorithms - during peer review
- The Interactive Compendium of Health Datasets for Economists
- Decision Modelling for Health Economic Evaluation
- Handbooks in Health Economic Evaluation
- Economic Evaluation in Clinical Trials
- Applied Methods of Cost-effectiveness Analysis in Healthcare
- Applied Methods of Cost-Benefit Analysis in Health Care
- The influence of cost-effectiveness and other factors on NICE decisions
- HERC database of health economics and genomics studies
- Estimating pooled survival benefit using individual patient-level data meta-analyses in cost-effectiveness analysis of health care technologies: case and simulation study.
- Bayesian methods (model averaging and belief networks) when mapping from the Modified Rankin Scale to the EQ-5D
- Which health technologies, at what price and for whom: estimating the cost-effectiveness threshold for NICE and the NHS
- Management of low-grade dysplasia in ulcerative colitis in the UK National Health Service: the cost-effectiveness of immediate surgery versus ongoing surveillance.
- Impact of performance-based financing in a low resource setting: a decade of experience in Cambodia
- Modelling the cost of cancer: a system of equations approach to understanding inter-relationships
- Measuring uncertainty preferences for health
- Using CART to identify thresholds and hierarchies in funding decisions.
- Terrorism and Human Capital at Birth: Bomb Casualties and Birth Outcomes in Spain
- Understanding the underutilisation of evidence from economic evaluations in healthcare: a mixed methods design
- Cost-effectiveness - Lessons from the Global Response to HIV/AIDS
- Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
- Banning alcohol sales at night and hospital admissions in Germany
- Predicting cancer patients’ quality of life: an analysis of the relationship between utility, treatment regimes and time
- Opportunity costs of healthcare beds: How to estimate them properly?
- If you don't snooze you lose. Evidence on health and weight.
- TBC
- A Brief History of Economic Evaluation.
- The determinants of GP referrals and elective hospital admissions: a practice level study.
- Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures
- Cost-effectiveness modelling of the liver disease pathway.
- Prospects for the use of Mendelian Randomization in Economic Evaluation
- Dealing with missing quality of life data in clinical trials .
- Using discrete choice experiments to understand benefit-risk trade-offs
- What is the impact on alcohol purchases of increasing the price of sugary drinks?
- Incentives, Choice and Public Health Policy
- Macroeconomic Conditions and Opioid Abuse
- Missing data in randomised trials: beyond missing at random
- Are Public Hospitals Overcrowded? Evidence from Trauma and Orthopaedics in England
- Use of Rapid Reviews in Health Technology Assessment Processes – Effective or Impractical? A Review of the Irish System & Lessons for Others.
- Developing New Policies in Response to Rising Drug Prices in the U.S.
- Introducing rational healthcare prioritisation in Ghana: Methods and Challenges
- Value of Sample Information as a Tool for Clinical Trial Design
- EQ-5D-3L vs EQ-5D-5L: what are the consequences for cost-effectiveness in the UK?
- Carer and family effects in economic evaluation: an overview of recent research
- Using electronic health records in health economic modelling studies.
- Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis
- Discrete Choice Experiments to Inform Programming and C-E Modelling of HIV Prevention
- Tracking Progress towards Universal Health Coverage in Kenya
- How do FDA policies impact demand for cigarettes and e-cigarettes in the US tobacco market? Predictions from discrete choice experiments
- Estimating survival: Does patient reported quality of life matter?
- Do consumers respond to “sin taxes” heterogeneously? New evidence from the tax on sugary drinks using retailer scanner data
- Multi-Criteria Decision Analysis for Comparative Value Assessment throughout the Drug Lifecycle
- Implications of non-marginal budgetary impacts in health technology assessment.
- Health Preference Research: past, present and possible future
- A Direct Regression Approach to Decomposing Socioeconomic Inequality of Health